GH Research GHRS
NASDAQ GHRS
$27.79 -0.13 (-0.47%)
As of: Sep 4, 2026 · 1:36 PM EDT

GH Research (GHRS) Interest & Investment Income (2022 - 2026)

GH Research (GHRS) posted quarterly Interest & Investment Income of $2.5 million for Q4 2025, up 18.88% year-over-year from $2.1 million in Q4 2024, and down 9.74% quarter-over-quarter from $2.8 million in Q3 2025.

Analysis

GH Research (GHRS) Interest & Investment Income (2022 - 2026) Analysis & Trends

GH Research's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $2.5 million for Q4 2025.

  • In Q4 2025, Interest & Investment Income rose 18.88% year-over-year to $2.5 million; the TTM figure through Dec 2025 stood at $11.1 million (up 12.71% YoY), while the FY2025 annual figure was $11.1 million, up 12.71% from the prior year.
  • Interest & Investment Income for Q4 2025 stood at $2.5 million, down from $2.8 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $3.1 million in Q2 2025, with the low at $1.2 million in Q4 2022.
  • The 4-year median for Interest & Investment Income is $2.5 million (2024), against an average of $2.4 million.
  • The sharpest annual moves came in 2023 and 2024: Interest & Investment Income jumped 151.2% in 2023, then decreased 27.86% in 2024.
  • GH Research's Interest & Investment Income stood at $1.2 million in 2022, then surged by 151.2% to $2.9 million in 2023, then decreased by 27.86% to $2.1 million in 2024, then grew by 18.88% to $2.5 million in 2025.
  • Business Quant data shows GHRS's Interest & Investment Income at $2.5 million in Q4 2025, $2.8 million in Q3 2025, and $3.1 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.26 Bn 131.41 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.83 Bn 52.69 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 35.58 Mn
6 BeOne Medicines 39.94 Bn 34.84 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.19 Bn 31.88 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 5.13 Mn
9 Insmed 27.35 Bn 26.19 Bn 358.27 Mn 10.98 Mn
10 GH Research 1.70 Bn 1.33 Bn - 2.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.66 Mn
Mar 31, 2026 2.19 Mn
Dec 31, 2025 2.51 Mn
Sep 30, 2025 2.78 Mn
Jun 30, 2025 3.07 Mn
Mar 31, 2025 2.76 Mn
Dec 31, 2024 2.11 Mn
Sep 30, 2024 2.54 Mn
Jun 30, 2024 2.56 Mn
Mar 31, 2024 2.67 Mn
Dec 31, 2023 2.93 Mn
Sep 30, 2023 2.44 Mn
Jun 30, 2023 2.12 Mn
Mar 31, 2023 1.49 Mn
Dec 31, 2022 1.17 Mn